-+ 0.00%
-+ 0.00%
-+ 0.00%

Gilead Sciences Director Kelly A. Kramer Reports Sale of $1.76 Million in Common Shares

PUBT·11/16/2026 20:32:56
Listen to the news
Gilead Sciences Director Kelly A. Kramer Reports Sale of $1.76 Million in Common Shares
  • Gilead Sciences director Kelly A. Kramer sold 10,376 common shares on Nov. 12, 2026, at reported prices of $168.2255–$171.44.
  • Kramer also exercised non-qualified stock options for 10,376 common shares at $66.92 per share.
  • Following the transactions, Kramer directly held 1,339 common shares, according to the Form 4 dated Nov. 16, 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Gilead Sciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001629885-26-000008), on November 16, 2026, and is solely responsible for the information contained therein.